163 related articles for article (PubMed ID: 38254245)
1. Missense mutation of NRAS is associated with malignant progression in neurocutaneous melanosis.
Takahashi H; Natsumeda M; Hara N; Koyama A; Shimizu H; Miyashita A; Satake D; Mouri Y; Tsukano J; Kawabe K; Tsukamoto Y; Okada M; Ogura R; Yuki A; Umezu H; Kakita A; Ikeuchi T; Oishi M
Acta Neuropathol Commun; 2024 Jan; 12(1):14. PubMed ID: 38254245
[TBL] [Abstract][Full Text] [Related]
2. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.
Kinsler VA; Thomas AC; Ishida M; Bulstrode NW; Loughlin S; Hing S; Chalker J; McKenzie K; Abu-Amero S; Slater O; Chanudet E; Palmer R; Morrogh D; Stanier P; Healy E; Sebire NJ; Moore GE
J Invest Dermatol; 2013 Sep; 133(9):2229-36. PubMed ID: 23392294
[TBL] [Abstract][Full Text] [Related]
3. Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor.
Küsters-Vandevelde HV; Willemsen AE; Groenen PJ; Küsters B; Lammens M; Wesseling P; Djafarihamedani M; Rijntjes J; Delye H; Willemsen MA; van Herpen CM; Blokx WA
Acta Neuropathol Commun; 2014 Apr; 2():41. PubMed ID: 24713450
[TBL] [Abstract][Full Text] [Related]
4. Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.
Salgado CM; Basu D; Nikiforova M; Hamilton RL; Gehris R; Jakacki R; Panigrahy A; Yatsenko S; Reyes-Múgica M
Melanoma Res; 2015 Oct; 25(5):453-60. PubMed ID: 26266759
[TBL] [Abstract][Full Text] [Related]
5. NRAS
Girolami I; Cima L; Ghimenton C; Zannoni M; Mombello A; Riva G; Cirielli V; Corradi G; Vogrig A; Di Stefano G; Novelli L; Gessi M; Eccher A
Brain Tumor Pathol; 2018 Oct; 35(4):217-223. PubMed ID: 30145692
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.
Shih F; Yip S; McDonald PJ; Chudley AE; Del Bigio MR
Acta Neuropathol Commun; 2014 Oct; 2():140. PubMed ID: 25330907
[TBL] [Abstract][Full Text] [Related]
7. Making a mountain out of a molehill: NRAS, mosaicism, and large congenital nevi.
Gerami P; Paller AS
J Invest Dermatol; 2013 Sep; 133(9):2127-30. PubMed ID: 23949765
[TBL] [Abstract][Full Text] [Related]
8. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
Mitre V; Heym K; Clark GD; Venkatramani R
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
[TBL] [Abstract][Full Text] [Related]
9. Congenital Melanocytic Nevus Syndrome: A Case Series.
Recio A; Sánchez-Moya AI; Félix V; Campos Y
Actas Dermosifiliogr; 2017 Nov; 108(9):e57-e62. PubMed ID: 28110826
[TBL] [Abstract][Full Text] [Related]
10. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
11. Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update.
Sharouf F; Zaben M; Lammie A; Leach P; Bhatti MI
Childs Nerv Syst; 2018 Aug; 34(8):1471-1477. PubMed ID: 29948137
[TBL] [Abstract][Full Text] [Related]
12. Hereditary spastic paraplegia masqueraded by congenital melanocytic nevus syndrome: Dual pathogenesis of germline non-mosaicism and somatic mosaicism.
Sakaguchi Y; Uehara T; Sasaki M; Fujimura K; Kishi K; Kosaki K; Takenouchi T
Eur J Med Genet; 2020 Apr; 63(4):103803. PubMed ID: 31698101
[TBL] [Abstract][Full Text] [Related]
13. Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
Ruan Y; Kovalchuk A; Jayanthan A; Lun X; Nagashima Y; Kovalchuk O; Wright JR; Pinto A; Kirton A; Anderson R; Narendran A
Neuro Oncol; 2015 Jun; 17(6):822-31. PubMed ID: 25395461
[TBL] [Abstract][Full Text] [Related]
14. Mosaic NRASopathy n a child with giant melanocytic congenital naevus, epidermal hamartoma and bilateral nephroblastomatosis: clinical implication for follow-up.
Maridet C; Morice-Picard F; Gros A; Crivelli L; de la Fouchardière A; Vergier B; Taïeb A
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e258-e260. PubMed ID: 29314428
[No Abstract] [Full Text] [Related]
15. Intramedullary and retroperitoneal melanocytic tumor associated with congenital blue nevus and nevus flammeus: an uncommon combination of neurocutaneous melanosis and phacomatosis pigmentovascularis--case report.
Kurokawa R; Kim P; Kawamoto T; Matsuda H; Hayashi S; Yamazaki S; Hatamochi A; Mori S; Shimoda M; Kubota K
Neurol Med Chir (Tokyo); 2013; 53(10):730-4. PubMed ID: 24077274
[TBL] [Abstract][Full Text] [Related]
16. Sudden change of a large congenital melanocytic nevus to neurocutaneous melanosis.
Lee CJ; Park JH; Lee SI
J Craniofac Surg; 2006 Nov; 17(6):1216-8. PubMed ID: 17119434
[TBL] [Abstract][Full Text] [Related]
17. Neurocutaneous melanocytosis (melanosis).
Ruggieri M; Polizzi A; Catanzaro S; Bianco ML; Praticò AD; Di Rocco C
Childs Nerv Syst; 2020 Oct; 36(10):2571-2596. PubMed ID: 33048248
[TBL] [Abstract][Full Text] [Related]
18. [An adult case of neurocutaneous melanosis with acute exacerbation after a long asymptomatic period following excision of a melanocytic nevus].
Furukawa K; Kikui S; Takeshima T; Yamamoto T; Ozaki A
Rinsho Shinkeigaku; 2021 Dec; 61(12):844-850. PubMed ID: 34789628
[TBL] [Abstract][Full Text] [Related]
19. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
Kolin DL; Geddie WR; Ko HM
Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
[No Abstract] [Full Text] [Related]
20. Severe hydrocephalus caused by diffuse leptomeningeal and neurocutaneous melanocytosis of antenatal onset: a clinical, pathologic, and molecular study of 2 cases.
Uguen A; Laurent C; Samaison L; Boisselier B; Talagas M; Costa S; Aziza J; Mokhtari K; Le Maréchal C; Marcorelles P
Hum Pathol; 2015 Aug; 46(8):1189-96. PubMed ID: 26037215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
